drugset / Trial / NCT05218915
Basal Plus GLP1-ra on Glycemic Variability in CKD
RandomizedParallel-groupOpen-labelTreatment
Summary
To compare GLP-1 RA plus basal insulin (BGLP) versus basal-bolus (BB) insulin regimens on glycemic variability (GV) and time in range (TIR) in diabetes patients CKD stage 3-4
Timeline
- Start
- 2022-01-28
- Primary completion
- 2024-10-30
- Completion
- 2024-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dulaglutide | Peptide | — | Subcutaneous |
| Background | insulin degludec | Protein / enzyme biologic | — | — |